|
A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis Clinical research trials and A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis. A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis clinical trial. Participants frequently get the best healthcare available for their A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis  A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis
A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis
For Condition: Cytomegalovirus Retinitis,HIV Infections
Status: Completed
Sponsor(s): Agouron Pharmaceuticals ,
Synopsis: The purpose of this study is to see if it is safe and effective to give Viracept to AIDS patients who are already being treated for cytomegalovirus (CMV) retinitis.
Details:
Eligibility:
Study Type: Interventional, Treatment, Placebo Control, Safety Study
Minimum Age/Maximum Age: 13 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients must have: - HIV infection. - Newly diagnosed or first progression of CMV retinitis. Exclusion Criteria Prior Medication: Excluded: Prior therapy (or less than 2 weeks) with protease inhibitor other than saquinavir.
Total Enrollment:
Location and Contact Information:
Northwestern Univ / SOCA
Chicago, Illinois, 60611
United States
Baylor Univ
Houston, Texas, 77009
United States
Univ of California / UCI Med Ctr
Orange, California, 92868
United States
Univ of California / San Diego Treatment Ctr
San Diego, California, 92103
United States
Univ of Texas Med Branch
Galveston, Texas, 77555
United States
George Washington Univ
Washington D.C., District of Columbia, 20037
United States
Harbor UCLA Med Ctr
Torrance, California, 90502
United States
Univ of Southern California / LA County USC Med Cntr
Los Angeles, California, 90033
United States
Additional Information:
Study ID Numbers: 259A; Study 517,AG1343-517
Study Start Date:
Record last reviewed: May 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00002169
Other Hiv Infections Studies:
1. Double-Blind, Randomized, Placebo-Controlled Study of Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived) in ARC Patients
2. The Safety and Effectiveness of Ribavirin in the Early Stages of HIV-Infection
3. Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis carinii Pneumonia (PCP) in Patients with AIDS
4. Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination with AIDSVAX B/B
5. A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success with Itraconazole But Not with Fluconazole
Related Studies:
Other HIV Infections Clinical Trials
Other Texas Clinical Trials
Other Galveston Clinical Trials
A Study of Viracept in AIDS Patients with Cytomegalovirus Retinitis
|
|
|
|
|
|
|
|
